Inside Wall Street: Pfizer's Pipeline Looks Primed to Deliver
The stock of the world's largest drugmaker has been a laggard lately. But that could be soon changing if analysts who are pointing to a solid lineup of new products are right. They think the giant can easily offset the patent loss for Lipitor. Continue reading Inside Wall Street: Pfizer's Pipeline Looks Primed to Deliver Inside Wall Street: Pfizer's Pipeline Looks Primed to Deliver originally appeared on DailyFinance on Mon, 14 Jun 2010 07:30:00. Filed Under: Company News , Columns , Investing , Health Care , Pfizer , Bristol-Myers Squibb Permalink | Tweet this! | Comments
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here